Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Ezetimibe MeSH Descriptor Data 2025


MeSH Heading
Ezetimibe
Tree Number(s)
D03.383.082.301.550
Unique ID
D000069438
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000069438
Scope Note
An azetidine derivative and ANTICHOLESTEREMIC AGENT that inhibits intestinal STEROL absorption. It is used to reduce total CHOLESTEROL; LDL CHOLESTEROL, and APOLIPOPROTEINS B in the treatment of HYPERLIPIDEMIAS.
Entry Term(s)
(1-(4-fluorophenyl)-(3R)-(3-(4-fluorophenyl)-(3S)-hydroxypropyl)-(4S)-(4-hydroxyphenyl)-2-azetidinone)
Ezetimib
Ezetrol
SCH 58235
SCH-58235
SCH58235
Zetia
Pharm Action
Anticholesteremic Agents
Registry Numbers
EOR26LQQ24
0
Related Numbers
163222-33-1
Public MeSH Note
2016; EZETIMIBE was indexed under AZETIDINES 1998-2015
History Note
2016 (1998)
Date Established
2016/01/01
Date of Entry
2015/07/01
Revision Date
2016/05/31
Ezetimibe Preferred
SCH 58235 Narrower
Zetia Narrower
Ezetrol Narrower
page delivered in 0.151s